Devices from Nanobiosym, Zaiput are heading to space
The final frontier is calling for two Massachusetts medical device companies, with each winning a grant from the Massachusetts Life Sciences Center to conduct experiments in space.
Announced at the International Space Station R&D Conference in Boston today, the Life Sciences Center and The Center for the Advancement of Science in Space announced that two Cambridge biotechs — Nanobiosym Inc. and Zaiput Flow Technologies— would share the $500,000 grant. Nanobiosym says it will receive $300,000.
“Collaboration is one of our greatest strengths in Massachusetts, and through this first-ever collaboration between CASIS and the MLSC, local companies have had the unique opportunity to compete for funds to support innovative life sciences experiments on the International Space Station,” said Gov. Charlie Baker in a statement.
Elon Musk on the future of SpaceX, Hyperloop and satellite Internet
The projects will be shipped up to the International Space Station within six to 18 months.
Nanobiosym, which has created a diagnostic device that uses a drop of blood, saliva or other body fluid, will seek to detect the presence of a pathogen cultivated in zero gravity.
Scientists are eager to send up and evaluate organisms in space, which mutate more quickly in zero gravity, said Dr. Anita Goel, chairman and CEO of Nanobiosym, in an interview.